Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$41.57 USD
-0.88 (-2.07%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $41.61 +0.04 (0.10%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Earnings News For AMPH
-
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
-
Amphastar: Q1 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
-
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
-
Amphastar: Q4 Earnings Snapshot
-
Amphastar (AMPH) to Report Q4 Earnings: What's in the Cards?
-
Amphastar: Q3 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
-
Amphastar: Q2 Earnings Snapshot
-
Amphastar (AMPH) to Report Q2 Earnings: What's in the Cards?
-
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
-
Amphastar: Q1 Earnings Snapshot
-
Amphastar: Q4 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates
-
Amphastar Pharmaceuticals (AMPH) Q3 Earnings Meet Estimates
-
Amphastar: Q3 Earnings Snapshot
-
Earnings Preview: Amphastar Pharmaceuticals (AMPH) Q3 Earnings Expected to Decline
-
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
-
Amphastar: Q2 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
-
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
-
Amphastar Pharmaceuticals (AMPH) Tops Q4 Earnings and Revenue Estimates
-
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Beat Estimates
-
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: What to Know Ahead of Q3 Release
-
Amphastar Pharmaceuticals (AMPH) Meets Q2 Earnings Estimates